Improving the understanding of how these factors influence an individual's physical activity requirements will help advance the field and help move the field toward the development of more personalized physical activity recommendations.
So, the use of hiPSCs may contribute to the development of future personalized cell therapies and open new possibilities for the treatment of cancer patients.
Ultimately, an improved understanding of the clinical impact of PIK3CA mutations is critical for the development of optimally personalized therapeutics against breast cancer and other solid tumors.
We believe that the advances in molecular biology of lymphoma research can lead to an increased understanding of the cancer biomarkers that contribute to lymphoma progression and thus warrant the development of more personalized and specific lymphoma-targeted imaging agents and treatments.
Counseling topics included enhancement of HIV/AIDS knowledge, synthesis of risk incidents and risk patterns, and the development of a personalized risk reduction plan.
By integrating the genomic information stored in the NCBI databases within the RDF-enabled p-medicine data infrastructure which already includes RDF-based access to other relevant sources such as ArrayExpress [ 27] we hope to further enhance clinical and genomic information to foster the development of novel personalized drugs for cancer patients based on their genomic profile.
Advances in nanoplatform, nano-imaging, and nano-drug delivery will drive the future development of nanomedicine, personalized medicine, and targeted therapy.
Viviane Reding, the justice commissioner, announced its intention to overhaul the European Union's data protection rules to take account of the development of social networking, personalized advertising and other Web services that have raised privacy concerns.
Scientific medicine begins to permit the development of precision and personalized medicine through opening the "black box" of disease by beginning to explain the many differences seen in patients' responses to a particular disease or to a particular therapy.
The current report details the last 5-year developments of clinical and translational research in radiation oncology, especially the role of French teams in the development of personalized treatment.
